PMID: 2498965Jan 1, 1989Paper

Noradrenergic and opioidergic influences on the antinociceptive effect of clomipramine in the formalin test in rats

Psychopharmacology
M AnsuateguiM Feria

Abstract

Although tricyclic antidepressants are especially useful in the treatment of chronic pain conditions, most of the work about its mechanism of action has been made on acute pain tests. The present study was aimed at studying the role played by noradrenergic and opioidergic influences on the antinociceptive activity of subchronically administered clomipramine in the formalin test (a tonic pain model) in rats. Clomipramine produced antinociception after 7 days, administration (2.5 mg/kg/day), an effect equivalent to that obtained by acute morphine (5 mg/kg). The antinociceptive effect of clomipramine was inhibited by the following: nonspecific blocking of alpha 1- and alpha 2-adrenoceptors by phentolamine, specific blocking of alpha 1-adrenoceptors by prazosin; stimulation of alpha 2 receptors by clonidine; and blocking of the opioid receptors by naloxone. Blocking the alpha 2-receptors with yohimbine did not antagonize the effect of clomipramine. These results suggest that clomipramine produces antinociception in this test, partly via the participation of the endogenous opioid system and partly by further activating or potentiating previously activated noradrenergic pathways which are involved in the control of pain information.

References

Oct 1, 1979·Neuropharmacology·R T Malseed, F J Goldstein
Oct 1, 1986·Pain·J D LevineR McBryde
Jan 1, 1983·Clinical Neuropharmacology·T D Walsh
Feb 1, 1980·Biochemical Pharmacology·A Biegon, D Samuel
Aug 27, 1981·European Journal of Pharmacology·A EschalierJ C Pechadre
Jun 1, 1982·Neurology·C P WatsonJ Warsh
Aug 1, 1983·Naunyn-Schmiedeberg's Archives of Pharmacology·H P LorezG Haeusler
Jun 27, 1983·Life Sciences·F RigalJ C Pechadre

❮ Previous
Next ❯

Citations

Feb 26, 1998·Pharmacology, Biochemistry, and Behavior·I Korzeniewska-Rybicka, A Płaźnik
May 6, 2003·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Mohammad-Reza ZarrindastParastoo Mojtahedzadeh-Ardebili
May 1, 1997·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·J A MicóJ S Serrano
Nov 5, 2003·CNS Drugs·Gary McCleane
Jan 16, 2008·CNS Drugs·Gary McCleane
Mar 23, 2011·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·A M PeiróJ F Horga
May 28, 2004·Expert Opinion on Pharmacotherapy·Gary McCleane
Oct 1, 1992·Pain·A TjølsenK Hole
Sep 1, 2019·International Journal of Psychiatry in Medicine·Paul A Zarkowski
Jun 29, 2002·Anesthesia and Analgesia·Fumiko YokogawaAkiyoshi Hosoyamada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.